| Nov 13 |
Artiva Biotherapeutics misses Q3 estimates
|
| Nov 12 |
Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
|
| Nov 11 |
Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference
|
| Sep 10 |
Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference
|
| Aug 29 |
Artiva Biotherapeutics GAAP EPS of -$22.00
|
| Aug 29 |
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
|
| Aug 11 |
Wall Street Breakfast: The Week Ahead
|
| Jul 19 |
Artiva Biotherapeutics surges on trading debut
|
| Jul 19 |
Artiva Biotherapeutics announces pricing of upsized $167M IPO
|
| Jul 18 |
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering
|
